PeopleBio, Inc. (KOSDAQ:304840)
South Korea
· Delayed Price · Currency is KRW 2,680.00
-60.00 (-2.19%)
At close: Mar 27, 2025, 3:30 PM KST
PeopleBio Revenue
In the year 2024, PeopleBio had annual revenue of 3.73B KRW, down -16.20%. PeopleBio had revenue of 658.24M in the quarter ending December 31, 2024, a decrease of -49.34%.
Revenue
3.73B
Revenue Growth
-16.20%
P/S Ratio
15.00
Revenue / Employee
n/a
Employees
66
Market Cap
54.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.73B | -721.35M | -16.20% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | 507.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |